Chronic kidney disease (CKD) is a growing public health problem that affects 10% of Americans, increases morbidity and mortality, and imposes a huge economic burden. Persistent renal tubular injury is an important component of tubulointerstitial fibrosis (TIF), the common feature of progressive CKD of any etiology. Growth factors such as transforming growth factor-? (TGF??) are important determinants of how tubula epithelia respond to injury. Although excessive TGF-? signaling promotes TIF, blocking TGF-??using genetic tools results in increased tubular damage after mouse models of CKD, suggesting that TGF-??signaling has protective effects as well. TGF-??mediates many differet cellular effects including G1 arrest of cell cycle progression and epithelial de-differentiation. Tis proposal tests the hypothesis that TGF???signaling in the proximal tubule promotes survival ater chronic renal injury by inducing cell cycle arrest and epithelial de- differentiation. The first ai investigates how TGF-? alters cell cycle progression and how these changes affect epithelial survival using murine models of injury and pharmacologic inducers of G1 arrest. To test this, we will use genetically modified mice that lack the TGF?? receptor (T?RII) specifically in the proximal tubule and induce chronic kidney injury by either angiotensin/ uninephrectomy or aristolochic acid. We anticipate that mice lacking T?RII have impaired G1 arrest and reduced epithelial survival after injury and that this improves with administration of palbociclib, an FDA-approved inducer of G0/G1 cell cycle arrest. Proximal tubule cells with and without T?RII in vitro will be used to understand the signaling pathways through which TGF-? induces cell cycle arrest.
The second aim explores mechanisms whereby TGF????lters epithelial differentiation nd how these changes impact survival. The role of epithelial differentiation in chronic kidney injury will be defined using mice with epithelial-specific deletion of Snail, a key transcription factor downstream of TGF-?? Proximal tubule cells with and without T?RII will be transfected with siRNA and constructs in vitro to test the hypothesis that Snail mediates TGF-?-dependent de-differentiation.
The third aim defines how the Wnt/?-catenin pathway, important in renal injury, interacts with TGF-? to affect epithelial survival. Genetic models and cell culture techniques wil be used to test the hypothesis that TGF-? increases canonical Wnt/??catenin signaling to improve epithelial survival through increased de-differentiation and G0/G1 cell cycle arrest. This proposal uses innovative genetic approaches and a new strategy for analyzing injury in a quantitative and location-specific way. These studies will provide valuable insights into the rolesof cell cycle and epithelial plasticity in the epithelial response to CKD, focusing on the proximaltubule which is the target of acute kidney injury and a mediator of CKD. However, information about cell cycle, epithelial plasticity and response to chronic injury has implications beyond the kidney as most organ dysfunction results from chronic epithelial injury.

Public Health Relevance

Chronic kidney disease is a growing public health problem which affects 10% of Americans. The proposed studies will shed valuable insight into how tubular epithelia; the target of injury; respond to chronic renal injury using genetically modifiedmouse models; cell culture techniques; and an FDA-approved pharmacologic agent. These studies have the potential to broaden our understanding of how epithelia respond to chronic injury in other organs with important therapeutic implications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK108968-01
Application #
9079110
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Rys-Sikora, Krystyna E
Project Start
2016-06-13
Project End
2020-04-30
Budget Start
2016-06-13
Budget End
2017-04-30
Support Year
1
Fiscal Year
2016
Total Cost
$353,250
Indirect Cost
$128,250
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37240
Chung, Sungjin; Overstreet, Jessica M; Li, Yan et al. (2018) TGF-? promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration. JCI Insight 3:
Gewin, Leslie S (2018) Renal Tubule Repair: Is Wnt/?-Catenin a Friend or Foe? Genes (Basel) 9:
Gewin, Leslie S (2018) Renal fibrosis: Primacy of the proximal tubule. Matrix Biol 68-69:248-262
Chang, Yongen; Lau, Wei Ling; Jo, Hyunil et al. (2017) Pharmacologic Blockade of ?v?1 Integrin Ameliorates Renal Failure and Fibrosis In Vivo. J Am Soc Nephrol 28:1998-2005
Woodard, Lauren E; Cheng, Jizhong; Welch, Richard C et al. (2017) Kidney-specific transposon-mediated gene transfer in vivo. Sci Rep 7:44904
Viquez, Olga M; Yazlovitskaya, Eugenia M; Tu, Tianxiang et al. (2017) Integrin alpha6 maintains the structural integrity of the kidney collecting system. Matrix Biol 57-58:244-257
Overstreet, Jessica M; Wang, Yinqiu; Wang, Xin et al. (2017) Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis. FASEB J 31:4407-4421
Nlandu-Khodo, Stellor; Neelisetty, Surekha; Phillips, Melanie et al. (2017) Blocking TGF-? and ?-Catenin Epithelial Crosstalk Exacerbates CKD. J Am Soc Nephrol 28:3490-3503
Gewin, Leslie; Zent, Roy; Pozzi, Ambra (2017) Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int 91:552-560